Over 1.8 million nonprofits and charities for donors, volunteers and funders

2016 Top-Rated Nonprofit

Multidisciplinary Association For Psychedelic Studies

27,614 pageviews

Claim This Nonprofit

More Info

Add to Favorites

Share this Nonprofit

Donate

Volunteering Oportunities

Nonprofit Overview

Causes: Government & Public Administration, Health, Medical Research, Mental Health, Mental Health Treatment

Mission: Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. MAPS furthers its mission by: -Developing psychedelics and marijuana into prescription medicines -Training therapists and working to establish a network of treatment centers -Supporting scientific research into spirituality, creativity, and neuroscience -Educating the public honestly about the risks and benefits of psychedelics and marijuana MAPS envisions a world where psychedelics and marijuana are safely and legally available for beneficial uses, and where research is governed by rigorous scientific evaluation of their risks and benefits.

Results: MAPS has completed two Phase 2 FDA studies using MDMA-assisted psychotherapy to treat PTSD, and is in the process of four other similar studies. MAPS also has a study looking at LSD-assisted psychotherapy for treating end-of-life anxiety, an outcome study of the benefits of ibogaine for opiate dependence, and a protocol to investigate medical marijuana to relieve symptoms of PTSD.

Target demographics: Any person whose life may be aided by the transformative nature of psychedelic psychotherapy

Geographic areas served: Worldwide

Programs: Maps' primary focus is research into mdma-assisted psychotherapy ($1,094,575), especially phase 2 research into mdma-assisted psychotherapy in subjects with chronic, treatment-resistant ptsd. In this fiscal year, maps treated the 18th subject in our charleston, south carolina mdma/ptsd study in 24 veterans, firefighters and police officers. An 8th subject was treated in our study in boulder, colorado for people suffering from ptsd from any source, a fourth subject was treated in our mdma/ptsd study in beer yaakov, israel, and an irb approved the amendments for our mdma/ptsd study in vancouver, canada. A 7th therapist participated in our mdma-assisted psychotherapy therapist training study. In addition to our core clinical research, this fiscal year we began planning a series of studies in collaboration with researchers who work with the u. S. Department of veterans affairs' national center for ptsd. We'll be exploring the use of mdma along with more traditional psychotherapeutic methods for treating ptsd including cognitive-behavioral conjoint therapy, cognitive processing therapy, and prolonged exposure therapy. We also began our study looking at the safety and efficacy of using mdma-assisted therapy for anxiety in adults on the autism spectrum and began preparations for a study of mdma-assisted psychotherapy for end-of-life anxiety. These studies will grow significantly in the coming year. Mdma-study related program expenses include costs of video data storage and streaming systems development, budgeting, contracting, and meetings; the costs of developing the treatment manual; training therapists; blinded therapist adherence training; and costs of reviewing and documenting all published mdma literature. There are also mdma-study related supervision of therapists, presentation of our data at professional conferences, and costs to manage the mdma purchased early in our work and to secure the drug for phase 3 trials expected to begin in 2016. Clinical research general costs cover the development of the infrastructure needed for our mdma clinical trials, including work with communications and fundraising departments, staff professional development and conferences, and video streaming and statistical software. Most of the clinical research expenses are personnel, including personnel at each study site: principal investigators, co-investigators, independent raters, overnight physicians, attendant, and study coordinators, as well as maps' internal staff: the clinical director, research associates, information specials, data coordinators and statistical consultants. Ibogaine research expenses were dedicated to completing our studies in mexico ($3,816), and new zealand ($6,329). Lsd research expenses ($12,185) were primarily used for the march 2014 publication of our lsd end-of-life anxiety article in the journal of nervous and mental disease. Marijuana research ($14,905) covered the costs of developing the protocol for a pilot study in which marijuana will be tested to manage symptoms in 76 veterans with chronic, treatment-resistant ptsd, and our efforts to end the public health service (phs) review and the national institute of drug abuse (nida) monopoly of the sale of marijuana for clinical research.

education expenses include harm reduction, events, publications and communications programs. Our zendo project provides a supportive space for people undergoing difficult psychedelic experiences in order to help turn those experiences into opportunities for learning and personal growth, and to reduce the number of drug-related psychiatric hospitalizations and arrests. Services were provided at five major events in fiscal year 2014: burning man (black rock city, nv), envision (costa rica), afrikaburn (south africa), bicycle day (san francisco, ca), and lightning in a bottle (bradley, ca). In order to share recent findings and to inspire existing and new support, maps produced events on psychedelic and marijuana research in colorado, vancouver and santa cruz; and attended more than 17 events that others produced, providing speakers, exhibits, sales of books and maps bulletins, and free distribution of clinical protocols and articles from peer-reviewed journals. Communications included publishing three maps bulletins, and 12 email newsletters, maintaining maps. Org, mdmaptsd. Org, mapscanada. Org, psychedelicscience. Org, and launching mdma-autism. Org. Maps produced "manifesting minds," with north atlantic books, reprinted albert hofmann's "lsd: my problem child," and began work with stanislav grof on his new book, "the visionary world of h. R. Giger. " in spring 2014, maps offered its first webinar, "psychedelic science," in collaboration with evolver learning labs. Maps saw significant growth in coverage of its work in social, online, and traditional media. Maps. Org had 511,449 unique visits and 1,809,246 page views. Facebook likes more than doubled to 89,282. Twitter followers increased 140%, to 17,099. Youtube subscriptions increased 256% to 5,313. Maps received 344 unique media mentions from online and print publications with significant reach. Media outlets include the los angeles times, the new york times, the san francisco chronicle, reason, scientific american, cnn, usa today, msnbc, time, associated press, fox news, forbes, nbc news, playboy, santa cruz sentinel, tricycle, business insider, npr, vice, and southern california public radio (kpcc).

this year, maps operationalized its long-running fiscal sponsorship program, clarifying and updating contracts, process, and structure. This program supports projects that are in alignment with maps mission and vision by offering donors a way to give to a 501(c) 3 nonprofit organization. Maps monitors the project budget, takes a small fee, and sends the donor a receipt for their contribution.

Community Stories

711 Stories from Volunteers, Donors & Supporters

Professional with expertise in this field

Rating: 5

MAPS has taken the lead in guts. It takes guts to dedicate time and energy to their cause, and it is truly a noble one. Psychedelics are to the mind what the telescope is to the cosmos. Their professionalism and dedication bring a level of legitimacy and publicity necessary to encourage honest discussion about these potentially groundbreaking tools. Keep up the good work.

Drake B.

General Member of the Public

Rating: 5

MAPS is an inspiration and is saving lives. Period.
They are helping us understand the human psyche better and leading us to a future of greater mental health through connection with eachother, the planet and Source.

Dawn96

General Member of the Public

Rating: 5

My son suffers from PTSD and has tried many prescription drugs none have helped and many made it worse. He has only found relief with cannabis but in most places cannot get medical card for this condition and continues to suffer. I am thankful to MAPS for supporting research and use of these alternatives!

Leana L.

Professional with expertise in this field

Rating: 5

MAPS gives hope to us that we can end the insanity and uninformed hysteria and illegality that surrounds the issue of plant medicines and psychedelics. These medicines have been shown throughout history and throughout the world to be supportive to health and happiness. The current epidemic of PTSD and stress related psychological disorders is threatening the very fabric of our society. This organization is bringing information forward to support responsible research and the healing use of currently illegal substances to the people that will benefit from them. Ending unreasonable and unproductive incarceration of citizens is also important, the war on drugs is keeping us from having access to the very healing medicines that the modern world desperately needs. Thank you for supporting them

Mariusz J.

General Member of the Public

Rating: 5

I have suffered from PTSD and have coincidentally found out about MDMA being used to treat the symptoms, also found out about MAPS clinical studies and work to make marijuana and psychedelics a prsescription medicines. I am very thankful for their work, they've done a great job :) drugs that are prohibited work much better than pharmaceutical drugs, which makes me feel completely negative towards big pharma, they create customers, not cures. It's time for revolution !

Jason89

General Member of the Public

Rating: 5

After ten years of participating in AA to address what was a debilitating alcoholism I came to realize, as many scientists studying addiction pathology and treatment are now finding, that the 12 step model was not only horribly ineffective and unsuccessful- it actually hampered my recovery and personal growth. It was out of desperation that I saught out psychedelic therapy after researching addiction online for the better part of a year and I'm so incredibly thankful that I did as it not only ended my physical addiction it disabused me of the PTSD, toxic shame, and poisonous resentments that were the fuel for my discontent and compulsion to self-medicate with booze. I was relieved of my self centeredness and shown my roll in my own situation, I was blessed with a sense of increased empathy which allowed me to forgive those I was harboring resentments towards who had abused and neglected me as a child. This increased empathy was not temporary, and has continued to enrich my life two years later. I have also disabused myself of misleading neo con propaganda and denounced my previous stance as a militant atheist islamophobe I went from denouncing all of Islam to advocating for displaced and occupied Palestinians. Psychedelic therapy not only cured my addiction, it showed me addiction wasn't even disease- it was a symptom of a larger affliction I was unaware I even had- this condition was of a spiritual nature. Psychedelics didn't chemically cure me- they simply brought me into a spiritual place where I could heal myself. The power doesn't come from a chemical, it comes from us- I never knew I had this power within me. We all have this potential for healing, insight, growth of empathy, and MAPS is far and away at the forefront of the bringing psychedelic therapy research and the resulting conversation to the forefront, and this is why it is essential that we support them. Psychedelic therapy is absolutely thee future of addiction and trauma treatment and the future is happening... Now.

Donor

Rating: 5

Psychedelics are the only medicines that treat my schizoaffective disorder without side effects. MAPS has worked consistently to build the scientific and evidential framework to legalize this treatment. I'm proud to support MAPS.

Volunteer

Rating: 5

I have finally got some relief. Knowing MAPS work in helping the PTSD problem in our military. I feel that we have made a leap in to our future help with PTSD. And other related mental health problems. Thank You MAPS

1

General Member of the Public

Rating: 5

I have volunteered and donated to various non-profits over my many years. Some 6 or so years ago I became aware of the work of MAPS and attended my first conference in 2013. Was I ever impressed! What an extraordinary group of people are involved. I am still feeling the "workshop high" I left with and no it isn't something I smoke or ingest! Presenters were passionate about their work and it was heartening to observe that. It is clear that the work MAPS is doing has far-reaching possibilities to help people with serious and intractable health issues. There is an urgency to their work and I want to see them flourish.

General Member of the Public

Rating: 5

MAPS has been an invaluable resource in navigating my own mental health and understanding how tools such as MDMA have helped those with PTSD and other anxiety disorders. The fear surrounding psychedelic medicines has resulted in disinformation and prohibition, thus making it impossible for those in need to access these potentially life-saving medicines. I have enormous respect for an organization like MAPS, who are bringing much needed sanity and research to this field. Few have been brave enough to take on such work, given the nature of the drug war, legal complexities, and lack of financial gain. And so I am very grateful for MAPS and their work and hope that funding for this vital research continues to grow.

General Member of the Public

Rating: 5

If we want to heal this world, first we have to heal ourselves. Psychedelic agents can be used as incredible tools of healing, but in the wrong hands, with the wrong attitude, they can be very dangerous as well. MAPS is the organization which took up the task of finding a suitable, safe context for the use of psychedelic medicines, one which could be seamlessly integrated into our modern Western society.

Neither the psychedelic be-ins of the sixties, nor the Goa parties of the 90s, nor the traditional ayahuasca rituals of Amazonian tribes could be integrated in such a way that they reached more than a few percent of the population. It would be very difficult for most people to get over the somewhat "fringe" nature of these contexts. But psychedelic psychotherapy - which grew out of well-established Western traditions of psychology and psychiatry - could be a game changer.

Aundre S.

General Member of the Public

Rating: 5

I am a woman suffering with PTSD and extreme anxiety issues and have not yet found a treatment that helps my condition. I am hopeful at the prospect of new treatments and am excited to see a group working on this important issue.

General Member of the Public

Rating: 5

I value MAPS work because they are opening the paths to treatments possible for those suffering from several disorders. I have hope while keeping up with their research and their progress as I suffer from PTSD and know the benefits of the substances they are studying. MAPS has helped me spread awareness of the potential options available to us in our (hopefully) near future and removing the stigma of the substances described. For once, I've been able to have intelligent debates over two substances that MAPS has been studying without judgement that they're "just drugs used for partying". Its changing the mindset of many and planting the seed to change many more. I can't wait to see how MAPS flourishes over the coming years and I will be doing my best to support them to continue their marvelous work and helping me and many others like me to have a successful and happy life.

Territorio N.

Professional with expertise in this field

Rating: 5

MAPS is frontlining a battle for health and cognitive liberty. What else does matter?

Vector N.

General Member of the Public

Rating: 5

MAPS is fighting for our fundamental right of free self-determination over our adult bodies and minds.
This basic human right has been stolen from us by pharmacological fascism's counterproductive and historically falsified prohibition policy which guarantees tax-free profits in the billions to unregulated criminal cartels, while it effectively only prevents any control of access, age and quality. Air America, Iran-Contra, N987SA and the HSBC settlement clearly shows who is profiting from the corruption pyramid which is the base for the global tax-free Mafia monopoly. MAPS' research focus are medicines which are known to mankind for thousands of years and where stigmatized only recently(speaking in evolutionary time scales) by corrupt people like criminals, lying politicians, lobbyists, manipulative media empires, pharmacological fascists and religious fanatics. MAPS is researching our consciousness and how it can be modified with endogenous(like DMT) and exogenous(like LSD) psychotropic substances. They are not only restricted to psychedelic research and also research dissociatives like Ketamine and empathogens like MDMA, which also can have great therapeutic potential. They are fighting for mankind to restore our originally guaranteed universal dignity and humanity.

Zdravko S.

General Member of the Public

Rating: 5

The people at MAPS are passionate in their efforts to bring health and peace to many patients for whom traditional therapies have proved unhelpful. They are also brave and principled professionals who are committed to a scientific inquiry in a field held back by social prejudice and misinformed political fear-mongering.

Go MAPS!

Shiva R.

General Member of the Public

Rating: 5

MAPS has worked tirelessly to do real research on substances with great healing merit that have been outlawed by our society for too long.

General Member of the Public

Rating: 5

I full agree with everything MAPS is doing and strongly believe in the healing powers of psychedelic medicines.

2

General Member of the Public

Rating: 5

It's simple really, they are the frontiers on a subject that has been demonized by the western world for far too long, without a legitimate reason.(There isn't a legit reason by the way)
People need to know this information regardless of their personal views on any "illicit drug" , since the information they are basing it upon is not generally fact, but propaganda, "morals" and miss-information. We need to re-educate the people on all "illicit drugs", not just psychedelics.

Sovereignty over our own minds and bodies should be a fundamental human right.
Without it, we are not free, we just pretend to be.

Sincerely
Robert . L

Ps, my dream is to work in this field, so if anyone is hiring ;)

Rip W.

General Member of the Public

Rating: 3

I support MAPS because after losing my left leg above knee in a motorcycle accident and almost losing my left arm, marijuana was the safest, most effective way to treat the anxiety and insomnia that came with the pain meds. Despite over a decade of 12 step work, it wasn't until I got to experience DMT that I was able to truly accept the life situation I found myself in, so I know the potential for hallucinogens used for healing in the appropriate settings and support further research.